Nevus Araneus (Spider Nevus) Follow-up
- Author: Ronald P Rapini, MD; Chief Editor: Dirk M Elston, MD more...
Deterrence/Prevention
No preventive measures are known for spider angioma (nevus araneus).
Complications
No significant complications are associated with spider angioma (nevus araneus); however, cosmetic issues may be of significant concern to some patients or to parents.
Prognosis
When not associated with underling pathology or pregnancy, spider angioma (nevus araneus) lesions may be permanent or may regress over a number of years. Recurrence is not uncommon after treatment.[16, 17, 18, 19, 20, 21, 22, 23]
In association with liver disease, lesions may resolve after liver transplantation.[6]
Spider nevi occurring in the context of pregnancy or oral contraceptive use may regress postpartum or after discontinuation of medicine.[5] They may also regress after death or in situations resulting in severe hypotension.[1]
Khasnis A, Gokula RM. Spider nevus. J Postgrad Med. Oct-Dec 2002;48(4):307-9. [Medline]. [Full Text].
Finn SM, Rowland M, Lawlor F, Kinsella W, Chan L, Byrne O, et al. The significance of cutaneous spider naevi in children. Arch Dis Child. Jul 2006;91(7):604-5. [Medline]. [Full Text].
Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol. Oct 1997;37(4):523-49; quiz 549-52. [Medline]. [Full Text].
Graham-Brown RA. Hepatobiliary System and the Skin. In: Irwin Freedberg AE, Klaus Wolff, K Frank Austen, Lowell Goldsmith, Stephen Katz, Thomas Fitzpatric. Fitzpatrick's Dermatology In General Medicine. Fifth. New York: McGraw-Hill; 1999:1918.
Henry F, Quatresooz P, Valverde-Lopez JC, Piérard GE. Blood vessel changes during pregnancy: a review. Am J Clin Dermatol. 2006;7(1):65-9. [Medline]. [Full Text].
Detry O, De Roover A. Images in clinical medicine. Spider angiomas. N Engl J Med. Jan 15 2009;360(3):280. [Medline]. [Full Text].
Akiyama M, Inamoto N. Arteriovenous haemangioma in chronic liver disease: clinical and histopathological features of four cases. Br J Dermatol. Mar 2001;144(3):604-9. [Medline]. [Full Text].
Niederau C, Lange S, Frühauf M, Thiel A. Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis. Liver Int. May 2008;28(5):659-66. [Medline]. [Full Text].
Salem A, Gamil H, Hamed M, Galal S. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. Jun 2010;24(6):649-54. [Medline]. [Full Text].
Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol. Feb 1999;94(2):502-7. [Medline]. [Full Text].
Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. Aug 10 1996;348(9024):370-4. [Medline]. [Full Text].
Li CP, Lee FY, Hwang SJ, Lu RH, Lee WP, Chao Y, et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol. Dec 2003;9(12):2832-5. [Medline]. [Full Text].
Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol. May 1999;34(5):520-3. [Medline]. [Full Text].
Iino S. [Differentiation alcoholic liver cirrhosis from viral liver cirrhosis]. Nippon Rinsho. Jan 1994;52(1):174-80. [Medline].
Collyer J, Boone SL, White LE, Rademaker A, West DP, Anderson K. Comparison of treatment of cherry angiomata with pulsed-dye laser, potassium titanyl phosphate laser, and electrodesiccation: a randomized controlled trial. Arch Dermatol. Jan 2010;146(1):33-7. [Medline]. [Full Text].
Sivarajan V, Al Aissami M, Maclaren W, Mackay IR. Recurrence of spider naevi following treatment with 585 nm pulsed dye laser. J Plast Reconstr Aesthet Surg. 2007;60(6):668-71. [Medline]. [Full Text].
Clark C, Cameron H, Moseley H, Ferguson J, Ibbotson SH. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci. 2004;19(1):1-5. [Medline]. [Full Text].
Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet Laser Ther. Dec 2001;3(4):169-73. [Medline]. [Full Text].
Kono T, Sakurai H, Groff WF, Chan HH, Takeuchi M, Yamaki T, et al. Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas. Lasers Surg Med. Feb 2006;38(2):112-5. [Medline]. [Full Text].
Michel JL. Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol. Mar-Apr 2003;13(2):136-41. [Medline].
Tan E, Vinciullo C. Pulsed dye laser treatment of spider telangiectasia. Australas J Dermatol. Feb 1997;38(1):22-5. [Medline]. [Full Text].
Tan OT, Gilchrest BA. Laser therapy for selected cutaneous vascular lesions in the pediatric population: a review. Pediatrics. Oct 1988;82(4):652-62. [Medline]. [Full Text].
Woo SH, Ahn HH, Kim SN, Kye YC. Treatment of vascular skin lesions with the variable-pulse 595 nm pulsed dye laser. Dermatol Surg. Jan 2006;32(1):41-8. [Medline]. [Full Text].

